Related Experiment Video
Updated: Jun 21, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
Comprehensive genomic characterization of early-stage bladder cancer
Frederik Prip1,2, Philippe Lamy1, Sia Viborg Lindskrog1,2
1Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Genomic analysis reveals significant variations in nonmuscle-invasive bladder cancer (NMIBC), with whole-genome doubling linked to poorer outcomes. Understanding these molecular differences is key for better patient risk assessment and treatment strategies.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Nonmuscle-invasive bladder cancer (NMIBC) requires improved risk stratification and treatment.
- Comprehensive molecular profiling is essential for understanding NMIBC heterogeneity.
Purpose of the Study:
- To comprehensively analyze the molecular landscape of NMIBC.
- To correlate genomic variations with clinical outcomes and molecular subtypes.
- To identify key drivers of disease aggressiveness in NMIBC.
Main Methods:
- Whole-exome sequencing (n=438), shallow whole-genome sequencing (n=362), and total RNA sequencing (n=414) were performed.
- Integrative clustering of multi-omics data was utilized.
- Genomic alterations, including loss of heterozygosity and whole-genome doubling (WGD), were analyzed.
Main Results:
- Significant genomic variation was observed in NMIBC, correlating with molecular subtypes.
- Frequent loss of heterozygosity in FGFR3 and 17p (TP53) was noted.
- Whole-genome doubling (WGD) occurred in 15% of tumors, associated with genomic instability, cell-cycle gene alterations, altered immune composition, and worse outcomes.
Conclusions:
- Genomic instability and immune cell exhaustion are critical factors in NMIBC aggressiveness.
- Multi-omics analysis provides insights into NMIBC molecular subtypes and progression.
- Findings support improved patient stratification for NMIBC based on molecular characteristics.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

